Breaking News Instant updates and real-time market news.

PHR

Phreesia

$30.00

0.36 (1.21%)

08:04
11/04/19
11/04
08:04
11/04/19
08:04

Phreesia appoints Randy Rasmussen as Chief Accounting Officer

Phreesia (PHR) announced the appointment of Randy Rasmussen as Chief Accounting Officer, reporting to Tom Altier, Phreesia's CFO, effective November 1. Most recently, he was a Senior Vice President and Controller with Medidata Solutions (MDSO).

  • 07

    Nov

PHR Phreesia
$30.00

0.36 (1.21%)

08/12/19
WBLR
08/12/19
INITIATION
WBLR
Outperform
William Blair views Phreesia as core holding in small-cap IT healthcare
William Blair analyst Ryan Daniels initiated coverage of Phreesia with an Outperform rating saying the company is a core small-cap healthcare IT holding. Phreesia is well positioned to benefit from "key mega trends" in the healthcare marketplace as the company's solutions address a critical but largely unmet need in the market, Daniels tells investors in a research note. He believes Phreesia has a "compelling" end-to-end product suite along with a "deep and experienced" management team.
08/13/19
JPMS
08/13/19
INITIATION
Target $33
JPMS
Overweight
Phreesia initiated with an Overweight at JPMorgan
JPMorgan analyst Anne Samuel started Phreesia with an Overweight rating and $33 price target. Through a software-as-a-service based platform, Phreesia offers healthcare providers a "top-ranked" suite of applications to manage the patient intake and payment processes via mobile, tablet, or kiosk, Samuel tells investors in a research note. He believes the company is positioned to benefit from the "important consumerization of healthcare trend." Phreesia has an estimated $7B addressable market but is less than 5% penetrated within that opportunity, says Samuel.
09/10/19
PIPR
09/10/19
NO CHANGE
Target $33
PIPR
Overweight
Phreesia Q2 showed strong revenue per client growth, says Piper Jaffray
Piper Jaffray analyst Sean Wieland kept his Overweight rating and $33 price target on Phreesia after its Q2 earnings beat in its first results as a public company. The analyst notes that the company generated strong annual growth in revenue per user and upside in its Life Sciences advertising business while also announced a new partnership with North Carolina to deliver the "Standardized Social Determinants of Health Screening Questions" to identify patients who have unmet social needs.
10/10/19
BARD
10/10/19
INITIATION
Target $31
BARD
Outperform
Phreesia initiated with an Outperform rating at Baird
Baird analyst Matthew Gillmor initiated coverage of Phreesia with an Outperform rating and $31 price target.

TODAY'S FREE FLY STORIES

EADSY

Airbus

$0.00

(0.00%)

06:08
12/13/19
12/13
06:08
12/13/19
06:08
Hot Stocks
Airbus acquires industrial automation company MTM Robotics »

Airbus has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$62.58

0.87 (1.41%)

06:06
12/13/19
12/13
06:06
12/13/19
06:06
Initiation
ConocoPhillips initiated  »

ConocoPhillips initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 23

    Mar

OGI

Organigram

$2.57

(0.00%)

06:06
12/13/19
12/13
06:06
12/13/19
06:06
Hot Stocks
Organigram gets Health Canada's approval for 16 additional cultivation rooms »

Organigram is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

OIS

Oil States

$17.64

0.55 (3.22%)

06:06
12/13/19
12/13
06:06
12/13/19
06:06
Downgrade
Oil States rating change  »

Oil States downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

SSNLF

Samsung

$0.00

(0.00%)

06:06
12/13/19
12/13
06:06
12/13/19
06:06
Periodicals
Samsung VP receives jail term for union-busting activities, Reuters reports »

Samsung Electronics VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$15.18

0.19 (1.27%)

06:04
12/13/19
12/13
06:04
12/13/19
06:04
Downgrade
Hanesbrands rating change  »

Hanesbrands downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGS

Regis

$17.31

0.15 (0.87%)

06:03
12/13/19
12/13
06:03
12/13/19
06:03
Hot Stocks
Regis enters franchise arrangement with Bushell Investment Group »

Regis announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTEN

Patterson-UTI

$10.38

0.29 (2.87%)

06:03
12/13/19
12/13
06:03
12/13/19
06:03
Downgrade
Patterson-UTI rating change  »

Patterson-UTI downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

PTEN

Patterson-UTI

$10.38

0.29 (2.87%)

06:03
12/13/19
12/13
06:03
12/13/19
06:03
Downgrade
Patterson-UTI rating change  »

Patterson-UTI downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

MOH

Molina Healthcare

$129.62

1.725 (1.35%)

06:00
12/13/19
12/13
06:00
12/13/19
06:00
Hot Stocks
Molina Healthcare announces $500M share repurchase program »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAN

Huntington Bancshares

$15.59

0.39 (2.57%)

05:58
12/13/19
12/13
05:58
12/13/19
05:58
Downgrade
Huntington Bancshares rating change  »

Huntington Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$271.45

0.74 (0.27%)

05:58
12/13/19
12/13
05:58
12/13/19
05:58
Periodicals
Apple acquires U.K.-based Spectral Edge, Bloomberg reports »

Apple has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UUGRY

United Utilities

$0.00

(0.00%)

05:55
12/13/19
12/13
05:55
12/13/19
05:55
Upgrade
United Utilities rating change  »

United Utilities upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HINOY

Hino Motors

$0.00

(0.00%)

05:54
12/13/19
12/13
05:54
12/13/19
05:54
Downgrade
Hino Motors rating change  »

Hino Motors downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAO

Youdao

$14.18

-0.17 (-1.18%)

05:54
12/13/19
12/13
05:54
12/13/19
05:54
Initiation
Youdao initiated  »

Youdao initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASAZY

Assa Abloy

$0.00

(0.00%)

05:53
12/13/19
12/13
05:53
12/13/19
05:53
Upgrade
Assa Abloy rating change  »

Assa Abloy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATDRY

Auto Trader Group

$0.00

(0.00%)

05:53
12/13/19
12/13
05:53
12/13/19
05:53
Upgrade
Auto Trader Group rating change  »

Auto Trader Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDNNY

Boliden

$0.00

(0.00%)

05:51
12/13/19
12/13
05:51
12/13/19
05:51
Downgrade
Boliden rating change  »

Boliden downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$220.43

0.37 (0.17%)

, REGN

Regeneron

$372.10

-1.41 (-0.38%)

05:39
12/13/19
12/13
05:39
12/13/19
05:39
Recommendations
Vertex, Regeneron analyst commentary  »

Credit Suisse replaces…

VRTX

Vertex

$220.43

0.37 (0.17%)

REGN

Regeneron

$372.10

-1.41 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

OPI

Office Properties

$32.93

-1.02 (-3.00%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Downgrade
Office Properties rating change  »

Office Properties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOLVY

Volvo

$0.00

(0.00%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Hot Stocks
Volvo appoints Scott Rafkin as Chief Digital Officer »

Scott Rafkin, currently…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$236.18

2.22 (0.95%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Recommendations
Amgen analyst commentary  »

Amgen price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

05:36
12/13/19
12/13
05:36
12/13/19
05:36
Upgrade
Nordson rating change  »

Nordson upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$111.41

-1.85 (-1.63%)

05:35
12/13/19
12/13
05:35
12/13/19
05:35
Downgrade
Neurocrine rating change  »

Neurocrine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

05:35
12/13/19
12/13
05:35
12/13/19
05:35
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.